TickerFacts.

Enveric Biosciences, Inc. (ENVB): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$5.2K
Year ended 2023-12-31
$584.2K2021-12-31: $189.7K2022-12-31: $584.2K2023-12-31: $5.2K$5.2K
2021-12-31 Capital Expenditures (USD) 2023-12-31
Period endedCapital ExpendituresChange YoYSource filing
2023-12-31$5.2K-99.1%2025-03-28, From 2023-01-01
2022-12-31$584.2K+207.9%2024-03-26, From 2022-01-01
2021-12-31$189.7Kn/a2023-06-09, From 2021-01-01